Dihydropyridines · What Are They, Mechanism of Action, Indications, Side Effects, and More

Published: Sep 23, 2025
Author: Anna Hernández, MD
Editor: Ahaana Singh
Editor: Lisa Miklush, PhD, RN, CNS
Illustrator: Aileen Lin
7-day free trial

Go deeper with Osmosis

Osmosis is a learning platform with videos, questions, and AI tools to help you master topics like this.

4.8 · 12,000+ reviews
Watch quick, visual videos
Practice with Qbank-style questions
Use AI to explain, quiz, and review
Study anytime with the mobile app
Start free trial

No credit card · Cancel anytime

What are dihydropyridines?

Dihydropyridines are a type of calcium channel blocker (CCB), which refer to a group of medications that block calcium channels located in the muscle cells of the heart and arterial blood vessels, thereby reducing the entry of calcium ions into the cell. By blocking these channels, CCBs promote blood vessel dilation (i.e., vasodilation), as well as changes in heart function, including reductions in heart rate, strength of contractility, and speed of conduction within the heart.  

Overall, these effects contribute to a drop in blood pressure and a decrease in the oxygen requirements of the heart. Because of these cardiovascular effects, CCBs can be used to treat hypertension (i.e., high blood pressure), among other heart problems, including angina and cardiac arrhythmias (i.e., disturbances in the heart rhythm).  

Learn deeper with Osmosis

Master this topic faster with videos, questions, and AI.

Used by 8M+ healthcare learners.

Start free trial

No credit card · Cancel anytime

Which calcium channel blockers are dihydropyridines?

According to their main site of action, CCBs can be categorized into two main classes: dihydropyridines and non-dihydropyridines, each with different uses and side effects.  

Dihydropyridines act predominantly on blood vessels to promote vasodilation without having much of a direct effect on cardiac function. They include medications that end with the suffix “-dipine”, such as nifedipine, nicardipine, nimodipine, and amlodipine, to name a few.   

On the other hand, non-dihydropyridines have a greater effect on the heart but are less effective in promoting vasodilation. Non-dihydropyridines include fewer medications, such as verapamil and diltiazem 

What is the mechanism of action of dihydropyridines?

Dihydropyridines work by binding to and blocking voltage-gated L-type calcium channels found on smooth muscle cells of arterial blood vessels. Usually, these channels open in response to an electrical signal, or action potential, hence the name “voltage-gated” L-type calcium channels. These calcium channels are responsible for regulating the entry of extracellular calcium into muscle cells, which in turn stimulates muscular contraction of blood vessels. By blocking these channels, dihydropyridines are able to decrease blood vessel contraction, leading to sustained vasodilation. In turn, vasodilation reduces vascular resistance of arterial blood vessels, leading to a drop in blood pressure 

What are dihydropyridines used for?

Dihydropyridines can be used for a variety of conditions that relate to increased vascular resistance, or increased contraction of blood vessels. Most commonly, they are used to treat hypertension by way of vasodilation. Additionally, some dihydropyridines, like nifedipine, can be given to treat high blood pressure in pregnant individuals.  

In addition, long-acting dihydropyridines can be used to treat vasospastic or Prinzmetal angina, which is caused by the narrowing of the blood vessels that supply blood to the heart (i.e., coronary arteries). In such cases, dihydropyridines can dilate the coronary arteries, increasing blood flow to the heart muscle. Moreover, they can also be used to prevent stable angina, a sudden chest pain that results from a compromised oxygen supply to the heart.  

Dihydropyridines can also be used to treat Raynaud syndrome, a medical condition caused by the narrowing of the small arteries of the fingertips when exposed to cold temperatures or stress. Furthermore, some dihydropyridines, such as nifedipine, can also be used to slow down uterine contractions in pregnant individuals at risk of preterm birth, thereby reducing the risk of neonatal complications. Lastly, nimodipine can be used to prevent cerebral vasospasm (i.e. a sudden narrowing of the cerebral blood vessels), a serious complication that can arise after the development of a subarachnoid brain hemorrhage, or the bleeding within the protective membranes that surround the brain and spinal cord. 

What are the side effects of dihydropyridines?

Dihydropyridines are generally well tolerated amongst individuals. However, in some cases, they may amplify their own effects, causing unwanted side effects. For example, excessive vasodilation can result in low blood pressure, headaches, dizziness, and facial flushing. Similarly, short-acting dihydropyridines can cause a sudden drop in blood pressure, which can cause activation of the sympathetic nervous system, leading to reflex tachycardia (i.e., an increased heart rate). In turn, this can lead to palpitations. Another common side effect is ankle swelling, which can result from increased leakage of fluid from blood vessels. Finally, gingival hyperplasia (i.e., enlargement of the gums) is a rare side effect that can be seen with certain dihydropyridines, such as nifedipine 

What are the most important facts to know about dihydropyridines?

Dihydropyridines (e.g., nimodipine, nifedipine, amlodipine) are a type of calcium channel blocker, a group of medications that block calcium channels located in the muscle cells of the heart and blood vessels. Because of their selective effect on arterial blood vessels, dihydropyridines are mainly used to decrease vascular resistance and blood pressure and therefore are used to treat hypertension. Other uses of dihydropyridines include preventive treatment of stable angina, Raynaud syndrome, and cerebral vasospasm. Possible side effects include headaches or dizziness, palpitations, ankle swelling, and, rarely, enlargement of the gums 

Key Takeaways

Definition 

Type of calcium channel blocker (CCB) that act mainly through vasodilation, making them commonly used in the treatment of hypertension 

CCBs 

- CCBs are divided into:  

     - Dihydropyridines  

          - Main effect: vasodilation  

          - “-dipine” suffix 

     - Non-dihydropyridines  

           - Main effect: reduction of heart rate, strength of contraction, and speed of conduction 

Mechanism of Action 

- Bind and block voltage-gated L-type calcium channels on smooth muscles cells of arterial blood vessels → blocked calcium influx into muscle cells → decreased blood vessel contraction → sustained vasodilation → decreased resistance → decreased blood pressure  

Uses 

- Hypertension  

- Vasospastic or Prinzmetal angina  

- Stable angina  

- Raynaud syndrome  

- Reduce uterine contraction in preterm labor  

- Prevention of cerebral vasospasm  

Side Effects

- Low blood blood pressure, headaches, dizziness, facial flushing  

- Sudden drop in blood pressure → reflex tachycardiapalpitations  

- Ankle swelling  

- Gingival hyperplasia  

Students say Osmosis is 100% worth it

Because Osmosis saves them time. Lowers stress. And actually helps them remember when it counts.

I used Osmosis to prepare for my first medical school licensing exam! Super helpful and interactive for people who may not do great with just pages of text info!

Cecilia Ruiz

Cecilia Ruiz

MD student

Sayan Misra

I have used Osmosis for about four years. Best thing I have ever used for my medical studies.

Sayan Misra

Sayan Misra

Med student

Osmosis videos are superior because they define simple concepts, tell a story with a clear progression, and provide context.

Jay Pate

Jay Pate

Dental student

References


Ioulios P, Charalampos M, Efrossini T. The spectrum of cutaneous reactions associated with calcium antagonists: A review of the literature and the possible etiopathogenic mechanisms. Dermatol Online J. 2003;9(5):6. Accessed December 9, 2020. https://pubmed.ncbi.nlm.nih.gov/14996379/


Khan JM, Beevers DG. Management of hypertension in ethnic minorities. Heart. 2005;91(8):1105–1109. doi:10.1136/hrt.2004.044560


Kuruvilla ME, Sanan N. Amlodipine-induced angioedema: An unusual complication of a common medication. Allergy Rhinol (Providence). 2018;9:1–3. doi:10.1177/2152656718764139


Picard F, Sayah N, Spagnoli V, Adjedj J, Varenne O. Vasospastic angina: A literature review of current evidence. Arch Cardiovasc Dis. 2018;112(1):44–45. doi:10.1016/j.acvd.2018.08.002


Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104. doi:10.1093/eurheartj/ehy339